Cumming J N, Wang D, Park S B, Shapiro T A, Posner G H
Department of Chemistry, School of Arts and Sciences, Johns Hopkins University, Baltimore, Maryland 21218, USA.
J Med Chem. 1998 Mar 12;41(6):952-64. doi: 10.1021/jm970711g.
Novel C4-(hydroxyalkyl)trioxanes 5d and 5e were designed and synthesized based on an understanding of the molecular mechanism of action of similar 1,2,4-trioxanes structurally related to the antimalarial natural product artemisinin (1). In vitro efficacies of these two new pairs of C4-diastereomers against chloroquine-sensitive Plasmodium falciparum support conclusions about the importance to antimalarial activity of formation of a C4 radical by a 1,5-hydrogen atom abstraction. Derivatives 6, 7, and 21 of C4 beta-substituted trioxane alcohols 4a, 5d, and 5e were prepared, each in a single-step, high-yielding transformation. Four of these new analogues, 6a-c and 7, are potent in vitro antimalarials, having 140 to 50% of the efficacy of the natural trioxane artemisinin (1).
基于对与抗疟天然产物青蒿素(1)结构相关的类似1,2,4 - 三恶烷分子作用机制的理解,设计并合成了新型C4 -(羟烷基)三恶烷5d和5e。这两对新的C4 - 非对映异构体对氯喹敏感的恶性疟原虫的体外药效支持了关于通过1,5 - 氢原子提取形成C4自由基对抗疟活性重要性的结论。制备了C4β - 取代的三恶烷醇4a、5d和5e的衍生物6、7和21,每个都是通过单步、高产率转化制备的。这些新类似物中的四种,即6a - c和7,是有效的体外抗疟药,其药效为天然三恶烷青蒿素(1)的140%至50%。